BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16645210)

  • 1. Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts.
    Wang YL; Lee JW; Cesarman E; Jin DK; Csernus B
    J Mol Diagn; 2006 May; 8(2):231-9. PubMed ID: 16645210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].
    Xing W; Gu BW; Zhu YM; Jiang CL; Zhao RH; Wang AH; Sun HP; Li JM; Shen ZX; Chen Z; Chen SJ
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):453-7. PubMed ID: 15854550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Glucuronidase is an optimal normalization control gene for molecular monitoring of chronic myelogenous leukemia.
    Lee JW; Chen Q; Knowles DM; Cesarman E; Wang YL
    J Mol Diagn; 2006 Jul; 8(3):385-9. PubMed ID: 16825513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of
    DE Oliveira Sales L; Mesquita FP; DE Sousa Portilho AJ; DE Moraes Filho MO; DE Moraes MEA; Montenegro RC; Moreira-Nunes CA
    In Vivo; 2019; 33(4):1119-1124. PubMed ID: 31280200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
    Bolufer P; Sanz GF; Barragán E; Sanz MA; Cervera J; Lerma E; Senent L; Moreno I; Planelles MD
    Haematologica; 2000 Dec; 85(12):1248-54. PubMed ID: 11114130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage.
    Elmaagacli AH; Beelen DW; Opalka B; Seeber S; Schaefer UW
    Ann Hematol; 2000 Aug; 79(8):424-31. PubMed ID: 10985361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of bcr/c-abl mRNA in chronic myelogenous leukemia by polymerase chain reaction to identify chromosome translocation.
    Lin CP; Chen PM; Yen JS; Wang RL; Lee LS; Chen PH; Chang JG
    J Formos Med Assoc; 1992 Mar; 91(3):247-51. PubMed ID: 1354683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of the BCR-ABL transcript using the Cepheid Xpert BCR-ABL Monitor assay.
    Dufresne SD; Belloni DR; Levy NB; Tsongalis GJ
    Arch Pathol Lab Med; 2007 Jun; 131(6):947-50. PubMed ID: 17550324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay.
    Preudhomme C; Révillion F; Merlat A; Hornez L; Roumier C; Duflos-Grardel N; Jouet JP; Cosson A; Peyrat JP; Fenaux P
    Leukemia; 1999 Jun; 13(6):957-64. PubMed ID: 10360386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time quantitative reverse transcriptase polymerase chain reaction.
    Fan H; Robetorye RS
    Methods Mol Biol; 2010; 630():199-213. PubMed ID: 20300999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR.
    Rulcová J; Zmeková V; Zemanová Z; Klamová H; Moravcová J
    Leuk Res; 2007 Apr; 31(4):483-91. PubMed ID: 16945414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.
    Hochhaus A; Lin F; Reiter A; Skladny H; Mason PJ; van Rhee F; Shepherd PC; Allan NC; Hehlmann R; Goldman JM; Cross NC
    Blood; 1996 Feb; 87(4):1549-55. PubMed ID: 8608246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed algorithm for the best detection of different bcr-abl gene fusion transcripts in molecular diagnostics laboratories: experience of a major referral center.
    Hoteit R; Mahfouz R
    Genet Test Mol Biomarkers; 2011 Apr; 15(4):227-9. PubMed ID: 21142814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALL- and CML-type BCR/ABL mRNA transcripts in chronic myelogenous leukemia and related disorders.
    Yokohama A; Karasawa M; Okamoto K; Sakai H; Naruse T
    Leuk Res; 1999 May; 23(5):477-81. PubMed ID: 10374861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
    Furukawa Y; Ju SL; Cho HL; Tatsumi N
    Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.
    Maran A; Waller CF; Paranjape JM; Li G; Xiao W; Zhang K; Kalaycio ME; Maitra RK; Lichtin AE; Brugger W; Torrence PF; Silverman RH
    Blood; 1998 Dec; 92(11):4336-43. PubMed ID: 9834240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis.
    Martinelli G; Testoni N; Montefusco V; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazzi F; de Vivo A; Pane F; Rosti G; Tura S
    Haematologica; 1998 Jul; 83(7):593-601. PubMed ID: 9718863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy.
    Malinge MC; Mahon FX; Delfau MH; Daheron L; Kitzis A; Guilhot F; Tanzer J; Grandchamp B
    Br J Haematol; 1992 Dec; 82(4):701-7. PubMed ID: 1482657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.